Cargando…
Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway
AIMS: In this report, it was investigated that hepatoma cells can cause downregulation of cytotoxic T lymphocyte (CTL) function and tea polyphenols (TPs) can reverse downregulation of CTL function. METHODS: The expression of GRP78, PD-1, and TIM-3 was detected by western blotting in CTLL-2 coculture...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576428/ https://www.ncbi.nlm.nih.gov/pubmed/36262827 http://dx.doi.org/10.1155/2022/6413783 |
_version_ | 1784811524974444544 |
---|---|
author | Guo, Mengnan Wang, Wei Bai, Wen Bai, Zekun Chen, Weixi Su, Yali Wu, Jinghua |
author_facet | Guo, Mengnan Wang, Wei Bai, Wen Bai, Zekun Chen, Weixi Su, Yali Wu, Jinghua |
author_sort | Guo, Mengnan |
collection | PubMed |
description | AIMS: In this report, it was investigated that hepatoma cells can cause downregulation of cytotoxic T lymphocyte (CTL) function and tea polyphenols (TPs) can reverse downregulation of CTL function. METHODS: The expression of GRP78, PD-1, and TIM-3 was detected by western blotting in CTLL-2 cocultured with Hepa1-6 cells. Moreover, perforin (PRF1) and granzyme B (GzmB) protein levels and ER morphology were examined by ELISA and TEM, respectively. After 4-phenylbutyric acid (4-PBA) or tunicamycin (TM) treatment, programmed cell death protein 1 (PD-1), and mucin domain 3 (TIM-3), PRF1, and GzmB were measured by western blotting and ELISA. After sh-CHOP or GSK2656157 (PERK inhibitor) stimulation, the activation of the PERK-CHOP pathway was detected in CTLL-2 cells. Finally, changes in PD-1, TIM-3, PRF1, and GzmB levels were detected to verify the reversal of CTL depletion by TP. RESULTS: The expression of GRP78, PD-1, and TIM-3 clearly increased, and swelling was observed for the endoplasmic reticulum (ER) in CTLL-2 cells cocultured with hepatoma cells. Concurrently, the levels of PRF1 and GzmB decreased. CTLL-2 depletion was induced after stimulation with TM and differed from 4-PBA stimulation. Treatment with sh-CHOP or GSK2656157 caused a decrease in PD-1 and TIM-3 expression, whereas the expression of PRF1 and GzmB clearly increased. After adding TP, the function of CTLs increased markedly. CONCLUSION: Hepatoma cells induced the depletion of CTLs through the ER stress PERK-CHOP pathway, and TP reversed this depletion by downregulating ER stress. |
format | Online Article Text |
id | pubmed-9576428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-95764282022-10-18 Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway Guo, Mengnan Wang, Wei Bai, Wen Bai, Zekun Chen, Weixi Su, Yali Wu, Jinghua Can J Gastroenterol Hepatol Research Article AIMS: In this report, it was investigated that hepatoma cells can cause downregulation of cytotoxic T lymphocyte (CTL) function and tea polyphenols (TPs) can reverse downregulation of CTL function. METHODS: The expression of GRP78, PD-1, and TIM-3 was detected by western blotting in CTLL-2 cocultured with Hepa1-6 cells. Moreover, perforin (PRF1) and granzyme B (GzmB) protein levels and ER morphology were examined by ELISA and TEM, respectively. After 4-phenylbutyric acid (4-PBA) or tunicamycin (TM) treatment, programmed cell death protein 1 (PD-1), and mucin domain 3 (TIM-3), PRF1, and GzmB were measured by western blotting and ELISA. After sh-CHOP or GSK2656157 (PERK inhibitor) stimulation, the activation of the PERK-CHOP pathway was detected in CTLL-2 cells. Finally, changes in PD-1, TIM-3, PRF1, and GzmB levels were detected to verify the reversal of CTL depletion by TP. RESULTS: The expression of GRP78, PD-1, and TIM-3 clearly increased, and swelling was observed for the endoplasmic reticulum (ER) in CTLL-2 cells cocultured with hepatoma cells. Concurrently, the levels of PRF1 and GzmB decreased. CTLL-2 depletion was induced after stimulation with TM and differed from 4-PBA stimulation. Treatment with sh-CHOP or GSK2656157 caused a decrease in PD-1 and TIM-3 expression, whereas the expression of PRF1 and GzmB clearly increased. After adding TP, the function of CTLs increased markedly. CONCLUSION: Hepatoma cells induced the depletion of CTLs through the ER stress PERK-CHOP pathway, and TP reversed this depletion by downregulating ER stress. Hindawi 2022-10-10 /pmc/articles/PMC9576428/ /pubmed/36262827 http://dx.doi.org/10.1155/2022/6413783 Text en Copyright © 2022 Mengnan Guo et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Guo, Mengnan Wang, Wei Bai, Wen Bai, Zekun Chen, Weixi Su, Yali Wu, Jinghua Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway |
title | Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway |
title_full | Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway |
title_fullStr | Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway |
title_full_unstemmed | Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway |
title_short | Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway |
title_sort | depletion and reversal of hepatocellular carcinoma inducing ctl through er stress-dependent perk-chop signaling pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576428/ https://www.ncbi.nlm.nih.gov/pubmed/36262827 http://dx.doi.org/10.1155/2022/6413783 |
work_keys_str_mv | AT guomengnan depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway AT wangwei depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway AT baiwen depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway AT baizekun depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway AT chenweixi depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway AT suyali depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway AT wujinghua depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway |